Related Experiment Video

Updated: May 28, 2026

Radiolabeling and Quantification of Cellular Levels of Phosphoinositides by High Performance Liquid Chromatography-coupled Flow Scintillation
10:52

Radiolabeling and Quantification of Cellular Levels of Phosphoinositides by High Performance Liquid Chromatography-coupled Flow Scintillation

Published on: January 6, 2016

Measuring PI3K lipid kinase activity

Elisa Ciraolo1, Alessia Perino, Emilio Hirsch

  • 1Department of Genetics, Biology and Biochemistry, Molecular Biotechnology Center, University of Torino, Torino, Italy.

Methods in Molecular Biology (Clifton, N.J.)
|October 1, 2011
PubMed

Insights

Class IA phosphoinositide-3 kinases (PI3Ks) are crucial in cancer survival and proliferation. This study details in vitro methods to measure PI3K lipid kinase activity, essential for testing new cancer drug efficacy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Class IA phosphoinositide-3 kinases (PI3Ks) signaling is integral to cellular survival and proliferation.
  • Aberrant PI3K pathway activation is common in many cancers, correlating with resistance to conventional chemotherapy.
  • The PI3K pathway's role in cancer cell growth validates PI3K as a significant therapeutic target.

Purpose of the Study:

  • To present methodologies for assessing PI3K lipid kinase activity in vitro.
  • To provide a standard procedure for evaluating the efficacy of novel PI3K inhibitors.

Main Methods:

  • In vitro assays to measure PI3K lipid kinase activity.
  • Standardized protocols for inhibitor efficacy testing.

Main Results:

  • Established methods for quantifying PI3K lipid kinase activity.
  • Validated procedures for screening PI3K inhibitors.

Conclusions:

  • Accurate measurement of PI3K activity is critical for cancer drug development.
  • In vitro kinase assays are fundamental for advancing PI3K-targeted cancer therapies.

More Related Videos

Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes08:49

Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes

Published on: March 14, 2021

PIP-on-a-chip: A Label-free Study of Protein-phosphoinositide Interactions10:58

PIP-on-a-chip: A Label-free Study of Protein-phosphoinositide Interactions

Published on: July 27, 2017

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...